1. Home
  2. KBSX vs KLRS Comparison

KBSX vs KLRS Comparison

Compare KBSX & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

N/A

Current Price

$1.24

Market Cap

53.5M

ML Signal

N/A

Logo Kalaris Therapeutics Inc.

KLRS

Kalaris Therapeutics Inc.

HOLD

Current Price

$9.80

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
KLRS
Founded
1976
2019
Country
Taiwan
United States
Employees
394
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
46.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KBSX
KLRS
Price
$1.24
$9.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$20.67
AVG Volume (30 Days)
12.0K
58.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$2.14
52 Week High
$6.19
$11.90

Technical Indicators

Market Signals
Indicator
KBSX
KLRS
Relative Strength Index (RSI) 51.59 51.19
Support Level $1.07 $8.08
Resistance Level $1.27 $10.64
Average True Range (ATR) 0.06 1.08
MACD 0.01 -0.10
Stochastic Oscillator 58.82 55.50

Price Performance

Historical Comparison
KBSX
KLRS

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About KLRS Kalaris Therapeutics Inc.

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: